Navigation Links
Ulthera Appoints Greg Waller as Chief Financial Officer
Date:12/6/2011

MESA, Ariz., Dec. 6, 2011 /PRNewswire/ -- Ulthera, Inc. – a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology –  today announced that it has named Greg Waller as Chief Financial Officer (CFO), a newly created position at Ulthera.

(Photo: http://photos.prnewswire.com/prnh/20111206/NY17456-a)

(Photo: http://photos.prnewswire.com/prnh/20111206/NY17456LOGO-b)

"Greg's results-oriented skillset will play a vital role in further enhancing our sound corporate infrastructure as more and more cosmetic physicians in the U.S. and internationally adopt our device to help meet the ever-growing consumer demand for safe and effective non-invasive procedures," said Matthew Likens, president and CEO of Ulthera. "I am confident that Greg will provide steadfast leadership to ensure a strong financial future for our growing company, especially as we tap the potential of our platform technology."

Waller's three-and-a-half decades of experience showcases a solid track record of strategic financial growth for both privately held and publically traded companies. Most recently, Waller served as CFO of Universal Building Products, a manufacturer of concrete construction accessories. Prior to that, he held several leadership positions at Sybron Dental Specialties, Inc., a manufacturer and marketer of consumable dental products. During his 25-year tenure with Sybron, he was instrumental in the IPO of the company and in more than 30 company acquisitions worldwide. He also played a pivotal role in supporting the growth of the company from 100 to more than 4,000 employees and from $10 million to more than $750 million in sales.

Waller currently serves as a board member and audit committee chairman for Endologix, Inc. and as a board member for Sunshine Heart, Inc. Additionally, he previously served as board member and audit committee chairman for Alsius, Inc., Biolase, Inc., Cardiogenesis Inc., Clarient, Inc. and SenoRx, Inc., all publicly traded companies.

"Although a young company, the technology achievements, market penetration and clinical respect that Ulthera has garnered in such a short period of time is not only impressive and significant; it is an auspicious indicator of what's to come," stated Waller. "I am honored to be part of such a promising company where medical innovation is highly encouraged, and consistency, safety and efficacy are at the heart of operating principals."

About Ulthera

Ulthera®, Inc. is a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com


'/>"/>
SOURCE Ulthera
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ulthera Announces $10.5 Million in Series C Venture Capital Funding
2. Ulthera CEO - Matthew Likens - to Present at Two Upcoming Healthcare Conferences
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. West Pharmaceutical Services, Inc. Appoints New Director
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Curemark Appoints Preeminent Pediatrics Gastroenterologist
7. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
10. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
11. NovaRx Appoints Industry Veteran as President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets ... Electronics 2015-2025: Applications, Technologies, Forecasts" report to ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, Composite ... Structural electronics involves electronic and/or electrical components and ... dumb structures such as vehicle bodies or conformally ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):